Literature DB >> 23690029

Opposing functions of PLAG1 in pleomorphic adenoma: a microarray analysis of PLAG1 transgenic mice.

Yang Wang1, Wenjun Shang, Xia Lei, Shukun Shen, Hongxin Zhang, Zhugang Wang, Lei Huang, Zhiwei Yu, Huishan Ong, Xuelai Yin, Wenjun Yang, Chenping Zhang.   

Abstract

Over-expression of the proto-oncogene pleomorphic adenoma gene 1 (PLAG1) plays a crucial role in the formation of pleomorphic adenoma, which is the most common type of salivary gland tumor. To understand the molecular mechanisms governing PLAG1-mediated tumorigenesis, we used a microarray-based approach to identify PLAG1 target genes. We validated the expression of several genes, including Bax, Fas, p53, p21, p16, Cyclin D1, Egfr, Trail-R/DR5, c-Fos, c-myc and Igf2, by real-time RT-PCR or western blotting. Using luciferase reporter gene assays, we determined that the promoters of Bax, Fas, p53, TRAIL-R/DR5, and c-Fos were transactivated by PLAG1. PLAG1 not only activates genes that promote cell proliferation and tumor formation but also genes that inhibit these cellular processes. Therefore, we conclude that PLAG1 may play a dual role in tumor formation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23690029     DOI: 10.1007/s10529-013-1213-7

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  7 in total

1.  NDRG1-PLAG1 and TRPS1-PLAG1 Fusion Genes in Chondroid Syringoma.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Kristin Andersen; Marius Lund-Iversen; Ingvild Lobmaier; Francesca Micci; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2020 May-Jun       Impact factor: 4.069

2.  PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: a comparative study with PLAG1 genetic abnormalities.

Authors:  Nora Katabi; Bin Xu; Achim A Jungbluth; Lei Zhang; Sung Y Shao; Jason Lane; Ronald Ghossein; Cristina R Antonescu
Journal:  Histopathology       Date:  2017-10-19       Impact factor: 5.087

3.  PLAG1 expression is maintained in recurrent pleomorphic adenoma.

Authors:  Beatriz Samara de Brito; Natália Giovanelli Gaspar; Erika Said Abu Egal; Celeste Sanchez-Romero; Antonio Santos Martins; Álfio José Tincani; Rogério de Oliveira Gondak; Oslei Paes de Almeida; Luiz Paulo Kowalski; Albina Altemani; Fernanda Viviane Mariano
Journal:  Virchows Arch       Date:  2016-07-06       Impact factor: 4.064

Review 4.  Interstitial Deletions Generating Fusion Genes.

Authors:  Ioannis Panagopoulos; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2021 May-Jun       Impact factor: 4.069

5.  Functional confirmation of PLAG1 as the candidate causative gene underlying major pleiotropic effects on body weight and milk characteristics.

Authors:  Tania Fink; Kathryn Tiplady; Thomas Lopdell; Thomas Johnson; Russell G Snell; Richard J Spelman; Stephen R Davis; Mathew D Littlejohn
Journal:  Sci Rep       Date:  2017-03-21       Impact factor: 4.379

6.  PLAG1 silencing promotes cell chemosensitivity in ovarian cancer via the IGF2 signaling pathway.

Authors:  Wei Huang; Bi-Rong Li; Hao Feng
Journal:  Int J Mol Med       Date:  2020-01-08       Impact factor: 4.101

7.  Dysregulated long non‑coding RNAs in pleomorphic adenoma tissues of pleomorphic adenoma gene 1 transgenic mice.

Authors:  Wanlin Xu; Limin Liu; Hao Lu; Jinye Fu; Chenping Zhang; Wenjun Yang; Shukun Shen
Journal:  Mol Med Rep       Date:  2019-04-11       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.